|
|
|
|
|
| March 29, 2012 | ISSUE NUMBER 244 VOL 8 |
|
Special Feature
Does Your Portfolio Review Include What Patients Really Want?
The quest for “radical” R&D innovation is often pursued at the expense of treatments with hidden blockbuster potential. Bert Spilker offers some suggestions to remedy the problem of screening out potentially important drugs that may not meet every item on the company’s checklist ...Read More
Comment
Behind the "Trade Dress" Debate
The elimination of “trade dress” protection for pill shapes and colors has been proposed as a measure for decreasing physician and patient reliance on brand-name drugs. But B. Brett Heavner has doubts about the argument ...Read More
Global
Parallel Importers Join Unlikely European Alliance
The spring in Europe has been marked by some unusual — even unprecedented — alliances in the world of pharmaceuticals. The most conspicuous example is a strategic coalition formed among some of the most unlikely bedfellows ever to snuggle down together under a common blanket: manufacturers, wholesalers, pharmacists and — believe it or not — parallel importers ...Read More
Advertisement
We've Created a Monster! Minimizing the Need for Multiple Systems to create a compliance framework
Event Date: April 11, 2012 at 11:00 AM Eastern Daylight Time
 Register for this Webcast! |
Biopharmaceuticals
Biopharma's Business Transformation
Pharm Exec’s upcoming webcast focuses on the evolution of the biopharma industry’s commercial business model, looking at how companies are transforming in response to change in a global market that demands more effective treatments and higher value from the healthcare spend, and presenting a step-by-step guide to managing that transformation
...Register here
|
|
|
 // Johnson & Johnson selected Alex Gorsky to succeed long-serving Chief Executive William Weldon at its annual meeting in April 2012.
// Sanofi-Aventis has appointed Jean-Luc Lowinski as its new Senior Vice President of the Asia region, effective May 1. He will be based in Shanghai, China. // Dr. Michael Stebbins, Assistant Director for Biotechnology in the Science Division of the White House Office of Science & Technology Policy, will be the keynote speaker at the 2012 MichBio Annual Business Meeting & Showcase on April 19 in Livonia, MI. // Healthcare agency CAHG (Chicago, IL) formed an alliance with TBWA\WorldHealth (New York, NY) to "strengthen its presence in the US".
|
|
Advertisement
Meeting Global Patient Demand for Access to Medicines Prior to Approval and Launch
On-Demand Webcast
 http://pharmexec.com/demand |
|
|
|
|
|
|
 |
|
|
 |
 |
|
 |
How important is it for your company to have a social media 'tsar'?
|
|
|
|
|
You
are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile.
To
ensure delivery to your Inbox, please add us to your
address book. If you need help doing this, click
here.
Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 1-866-529-2922 at any time, or fax us at 1-218-740-6417. Outside the U.S., please phone 1-218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.
|
|
